Home » News and Events » News & Studies » PHARMExcel, a U.K. based CRO, is delighted to have been selected as the CRO to support the COVBoost study. Data has contributed to the MHRA approval decisions
PHARMExcel, a U.K. based CRO, is delighted to have been selected as the CRO to support the COVBoost study. Data has contributed to the MHRA approval decisions
